Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Sinclair Pharma

Sinclair Pharma and IS Pharma are in merger discussions that would lead to the creation of a pan-European speciality pharmaceuticals group called Sinclair IS Pharma.

Sinclair Pharma has acquired Cranage Healthcare, the Cheshire-based distributor of woundcare products, for an initial £0.4m.

Sinclair Pharma has acquired the Flammazine and Flammacerium dermatology products from Solvay Pharmaceuticals for £16m.

Sinclair Pharma is to acquire Ashbourne Pharmaceuticals, the Northampton-based pharmaceuticals marketing company, for £1.3m.

Sinclair Pharmaceuticals is to acquire Group CS Dermatologie, the French skincare company, for £37m.

Sinclair Pharma is to acquire Euroderm, the Italian supplier of dermatology pharmaceuticals with 33 staff, for £4.2m.

Sinclair Pharmaceuticals has raised £22m in a share placing to fund the expansion of its drug development business.